Related Experiment Video
Updated: Jul 4, 2026
07:36
Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
Published on: May 16, 2020
Understanding structural/functional properties of immunoconjugates for cancer therapy by computational approaches
C Arcangeli1, C Cantale, P Galeffi
1Computing and Modeling Unit, ENEA Casaccia Research Center, Via Anguillarese 301, 00123 S.Maria di Galeria, Italy. caterina.arcangeli@casaccia.enea.it
Journal of Biomolecular Structure & Dynamics
|June 7, 2008
Summary
Computational methods predict that anti-HER2 immunoconjugates maintain antibody folding and enhance structural stability, even with a linked bacterial toxin. This approach aids in evaluating cancer therapeutics.
Area of Science:
- Biochemistry
- Computational Biology
- Oncology
Background:
- Immunoconjugates, combining antibodies with toxins, are a promising cancer therapy strategy.
- Targeting the HER2 receptor with antibodies is crucial for certain human cancers.
Purpose of the Study:
- To computationally evaluate physicochemical properties of two anti-HER2 immunoconjugates.
- To predict the effects of a bacterial toxin on antibody structure and dynamics.
Main Methods:
- In silico analysis using homology modeling and molecular dynamics simulations.
- Assessment of structural models and simulation trajectories for biochemical properties.
Main Results:
- Antibodies maintained correct folding despite toxin presence, showing some regional stiffness.
- Toxin linkage did not affect antibody solubility but enhanced structural stability.
Conclusions:
- The computational approach is a valuable tool for analyzing immunoconjugate properties.
- This method can predict toxin effects on antibody structure, dynamics, and function for cancer therapy development.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...